Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Add-on Study of Hydrochlorothiazide in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Olmesartan/Amlodipine Alone

NCT00902538 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00902538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00902538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Add-on Study of Hydrochlorothiazide in Patients With Moderate to Severe Hypertension Not Achieving Target Blood Pressure on Olmesartan/Amlodipine Alone
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
October 31, 2010
Enrollment
2,204 (actual)
Sites
117

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension